Medications

US panel sees risk in long-used osteoporosis drug

A panel of U.S. government health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer.

Medications

Beware fake flu treatments, FDA warns

(HealthDay)—With the height of flu season here, the U.S Food and Drug Administration warns consumers to avoid fraudulent products that claim to prevent, treat or cure the flu.

Diseases, Conditions, Syndromes

FDA approves first skin patch to combat migraines

(HealthDay News) —A skin patch for the treatment of migraines, and the intense waves of nausea that often accompany these debilitating headaches, has been approved by the U.S. Food and Drug Administration.

Psychology & Psychiatry

Oxytocin produces more engaged fathers and more responsive infants

A large body of research has focused on the ability of oxytocin to facilitate social bonding in both marital and parenting relationships in human females. A new laboratory study, led by Dr. Ruth Feldman from Bar-Ilan University ...

Medications

Tefina, a 'female Viagra', currently being studied

Tefina, the first testosterone based intranasal gel, has been in part developed by the ULg's Galenic Pharmacy Laboratory. It is currently at the stage of testing before being marketed by the Canadian company, Trimel Pharmaceuticals.

Medications

Swallowing nasal sprays, eye drops can harm kids, FDA warns

(HealthDay)—Over-the-counter eye drops or nasal decongestant sprays can pose a serious health threat to children who swallow them and should be kept out of the reach of kids at all times, the U.S. Food and Drug Administration ...

Medications

Next-generation vaccines—eliminating the use of needles

Lead scientist Professor Simon Cutting, from the School of Biological Sciences at Royal Holloway, has developed the jabs through the use of probiotic spores. He carried out fundamental studies into the biology of the bacterium ...

page 25 from 30